악성 상대정맥 증후군에서 경피적 스텐트삽입술 및 항응고제
치료에도 불구하고 지속적으로 재발하는 스텐트 내 혈전증
- 이상호; 심창우; 지호석; 이혜인; 최도일; 김흥태; 김현범; 이인준; 김선영
- Publication Year
- Anticoagulation; Endovascular treatment; Superior vena cava
- Endovascular treatment (EVT) including angioplasty and stenting is an effective treatment for superior vena cava (SVC) syndrome. Recurrence of SVC syndrome is mainly caused by tumor progression and occurs in around 20% after EVT, but sometimes venous thrombosis within stent accounts for recurrence of SVC syndrome. Anticoagulation after EVT is still a
controversial issue. In our case, a 73-year-old man with SVC syndrome caused by mediastinal metastasis from non-small cell lung cancer underwent endovascular stent followed by anticoagulation with low molecular weight heparin (LMWH), but symptomatic progression due to in-stent thrombosis necessitated the second procedure after two weeks. A
total of 4 sessions of endovascular stent and anticoagulation with LMWH, warfarin and rivaroxaban did not induce durable resolution of in-stent thrombosis. Our case suggests refractory in-stent thrombosis could develop despite of anticoagulation after endovascular stent for SVC syndrome.
- Alternative Title
- Intractable in stent thrombosis in malignant superior vena cava syndrome
- Keimyung University School of Medicine
- Keimyung Medical Journal, Vol.35(1) : 73-78, 2016
- Authorize & License
- Files in This Item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.